
In this article
Vaxcyte, Inc. shares are trading lower after announcing an upcoming webcast and conference call to present topline results from its VAX-24 Infant Phase 2 Study, causing investor uncertainty.

Vaxcyte, Inc. shares are trading lower after announcing an upcoming webcast and conference call to present topline results from its VAX-24 Infant Phase 2 Study, causing investor uncertainty.